Version 1
: Received: 20 June 2020 / Approved: 21 June 2020 / Online: 21 June 2020 (09:52:10 CEST)
How to cite:
Basu, M.; Saha, C.; Roy Choudhury, K.; Dutta, S.; Ghosh, S.; Chowdhury, S.; Mukhopadhyay, S.; Bhattacharyya, N.P. COVID-19 Comorbidity and Metabolic Syndrome: Is There a Molecular Basis?. Preprints2020, 2020060245. https://doi.org/10.20944/preprints202006.0245.v1
Basu, M.; Saha, C.; Roy Choudhury, K.; Dutta, S.; Ghosh, S.; Chowdhury, S.; Mukhopadhyay, S.; Bhattacharyya, N.P. COVID-19 Comorbidity and Metabolic Syndrome: Is There a Molecular Basis?. Preprints 2020, 2020060245. https://doi.org/10.20944/preprints202006.0245.v1
Basu, M.; Saha, C.; Roy Choudhury, K.; Dutta, S.; Ghosh, S.; Chowdhury, S.; Mukhopadhyay, S.; Bhattacharyya, N.P. COVID-19 Comorbidity and Metabolic Syndrome: Is There a Molecular Basis?. Preprints2020, 2020060245. https://doi.org/10.20944/preprints202006.0245.v1
APA Style
Basu, M., Saha, C., Roy Choudhury, K., Dutta, S., Ghosh, S., Chowdhury, S., Mukhopadhyay, S., & Bhattacharyya, N.P. (2020). COVID-19 Comorbidity and Metabolic Syndrome: Is There a Molecular Basis?. Preprints. https://doi.org/10.20944/preprints202006.0245.v1
Chicago/Turabian Style
Basu, M., Satinath Mukhopadhyay and Nitai P. Bhattacharyya. 2020 "COVID-19 Comorbidity and Metabolic Syndrome: Is There a Molecular Basis?" Preprints. https://doi.org/10.20944/preprints202006.0245.v1
Abstract
The risk factors associated with COVID-19 related severity, morbidity, and mortality, i.e., obesity (often associated with NAFLD), hyperglycemia, hypertension and dyslipidemia all cluster together as metabolic syndrome (MetS). Instead of studying association of these risk factors with COVID-19, it makes sense studying the association between MetS on one hand and COVID-19 on the other. This study explores a molecular basis underpinning the above association. Severity of COVID-19 patients with MetS could be due to functional alterations of host proteins due to their interactions with viral proteins. We collected data from Enrichr (https://amp.pharm.mssm.edu/Enrichr/), DisGeNET (https://www.disgenet.org/) and others and carried out enrichment analysis using Enrichr. Various biological processes and pathways associated with viral protein interacting partners are known to involve in metabolic diseases. The molecular pathways underlying insulin resistance, insulin signaling and insulin secretion are not only involved in diabetes but also in CVD and obesity (associated with non-alcoholic fatty liver disease; NAFLD). Lipid metabolism/lipogenesis, fatty acid oxidation and inflammation are associated with MetS. Viral interacting host proteins are associated and enriched with terms like hyperglycemia, coronary artery disease, hypertensive disease related to CVD and liver diseases in DisGeNET. Association of viral interacting proteins with disease-relevant biological processes, pathways and disease-related terms suggests that altered host protein function following interaction with viral proteins might contribute to frequent occurrence and/or severity of COVID-19 in subjects with MetS. Such analysis not only provides a molecular basis of comorbidity but also incriminates host proteins in viral replication, growth and identifies possible drug targets for intervention.
Keywords
COVID-19; Metabolic syndrome; Comorbidity; Enrichment analysis; biological processes and pathways
Subject
Biology and Life Sciences, Endocrinology and Metabolism
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
,
,
,
*
,
*
